| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 本公司由其前身天圣有限根据2007年11月29日作出的股东会决议和全体发起人签署的发起人协议整体变更设立而来。2007年12月29日，公司在重庆市工商行政管理局办理完了工商变更登记手续，并领取了注册号为500231000001009的《企业法人营业执照》。 发行人所处医药行业，主要从事医药制造与医药流通，是集医药研发、制造及流通为一体的医药企业集团。 报告期内，发行人的医药制药业务生产单位主要为天圣股份及下属四家控股公司——湖北天圣（康迪制药）、湖南天圣、四川天圣、天圣山西，主要生产销售各类口服固体制剂（包括片剂、硬胶囊剂、颗粒剂、丸剂等）、大容量注射剂、小容量注射剂、药用空心胶囊及中药饮片。公司可生产18个剂型、200余个药品品种，共拥有300余个国家药监总局核发的药品生产批准文号（含药用辅料与药品包装用材料），包括各类中成药、化学药、药用辅料、药用包装材料等，主导产品为小儿肺咳颗粒、红霉素肠溶胶囊、银参通络胶囊、延参健胃胶囊、血塞通注射液、氯化钠注射液、葡萄糖注射液。小儿肺咳颗粒、红霉素肠溶胶囊、血塞通注射液等77个药品品种进入了《国家基本药物目录》，小儿肺咳颗粒、红霉素肠溶胶囊、延参健胃胶囊、血塞通注射液、地贞颗粒等152个药品品种被列入《国家医保目录》，其中延参健胃胶囊、地贞颗粒为发行人独家品种。 发行人的医药流通业务主要由长圣医药、天圣药业两家控股公司向重庆地区各级医院销售、配送药品。 | ||||||||||||||||||||||||
| Main Business | 药物研发、生产、销售、中药材种植加工。 | ||||||||||||||||||||||||
| Legal Representative | 刘爽 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 王琴 | ||||||||||||||||||||||||
| Solicitors | 北京明税律师事务所 | ||||||||||||||||||||||||
| Auditors | 北京兴华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
| Tel No | 023-62910742 | ||||||||||||||||||||||||
| Fax No | 023-62980181 | ||||||||||||||||||||||||
| Website | www.tszy.com.cn | ||||||||||||||||||||||||
| zqb@tszy.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/05/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.293 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 6.577 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 0.778B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |